DATE: April 17, 2019TIME: 9:00am PDT...
DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
Developing and validating RUO targeted quantitative methods for clinical applications presents many challenges to researchers. Resulting LC-MSn methods cover diverse molecular classes of com...
In this webinar, Jessica DesLauriers will share how she transformed the Avera McKennan laboratory and health system's quality management system into a reliable, standardized system with...
Date: September 14, 2022 Time: 10:00am (PDT), 1:00pm (EDT), 7:00pm (CEST) Virus-like particles (VLPs) are nanostructures that possess diverse applications in therapeutics, immunization, and...
DATE: April 27, 2020 TIME: 9:00am PT, 12:00pm ET Recombinant adeno-associated virus (rAAV) is a small (25-nm) virus that is composed of a protein shell called a capsid and a single-stranded...
Date: September 15, 2021 Time: 9:00am (PDT), 12:00pm (EDT) Dr. Markus Kostrzewa will elaborate on the progress that has been made in Bruker Microbiology & Diagnostics, specifically on th...
Antibody-drug conjugates (ADCs) represent the most successful class of active targeting drug-delivery systems, however, despite the increasing number of FDA approvals treatment-related adver...
DATE: September 19, 2017TIME: 10:30am PDT/ 1:30pm EDT/ 7:30pm CESTPart 1 – Cigall Kadoch, Ph.D. (30 min.)Exome- and genome-wide sequencing studies in human cancer have...